XML 130 R75.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Reporting (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
USD ($)
entity
Dec. 31, 2024
USD ($)
Segment Reporting [Abstract]    
Number of reportable segments | entity 1  
Segment Reporting Information [Line Items]    
Research and development $ 24,903 $ 33,656
Employee related general and administrative expenses 12,811 11,330
Net loss (39,571) (51,898)
Total segment assets 25,862 28,178
Reportable Segment    
Segment Reporting Information [Line Items]    
Contract and grant reimbursements (754) (1,027)
Employee related general and administrative expenses 5,506 3,682
Professional fees and other general and administrative expenses 7,300 7,648
Other segment items 1,858 6,912
Net loss 39,571 51,898
Total segment assets 25,862 28,178
Clinical trial expenses | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development 9,602 15,892
Employee related research and development expenses | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development 8,915 8,560
Chemistry, manufacturing and controls expenses | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development 1,896 4,260
Other research and development expenses | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development $ 5,248 $ 5,971